Free Trial

Synthomer (LON:SYNT) Trading Down 20.1% - Time to Sell?

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc shares fell by 20.1% on Tuesday, dropping to GBX 63 ($0.84) from a previous close of GBX 78.80 ($1.05).
  • Research analysts have adjusted their target prices for Synthomer, with Jefferies maintaining a "hold" rating at GBX 100 ($1.33) and Deutsche Bank lowering theirs to GBX 115 ($1.53).
  • Insider Janet E. Ashdown purchased nearly 20,000 shares at approximately GBX 99 ($1.32), reflecting confidence in the company's long-term prospects despite recent stock volatility.
  • Looking to export and analyze Synthomer data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Synthomer plc (LON:SYNT - Get Free Report) traded down 20.1% during trading on Tuesday . The company traded as low as GBX 62 ($0.83) and last traded at GBX 63 ($0.85). 4,148,780 shares were traded during trading, an increase of 475% from the average session volume of 721,035 shares. The stock had previously closed at GBX 78.80 ($1.06).

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Berenberg Bank reduced their target price on shares of Synthomer from GBX 120 ($1.61) to GBX 80 ($1.08) and set a "hold" rating for the company in a report on Wednesday. Jefferies Financial Group restated a "hold" rating and set a GBX 100 ($1.34) target price on shares of Synthomer in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of Synthomer from GBX 140 ($1.88) to GBX 115 ($1.55) and set a "hold" rating for the company in a report on Wednesday, July 30th.

Check Out Our Latest Research Report on Synthomer

Synthomer Stock Down 2.8%

The business's 50 day moving average is GBX 98.97 and its 200 day moving average is GBX 109.20. The company has a debt-to-equity ratio of 78.27, a quick ratio of 0.97 and a current ratio of 1.90. The stock has a market cap of £102.60 million, a price-to-earnings ratio of -1.25, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79.

Synthomer (LON:SYNT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported GBX (5.40) (($0.07)) EPS for the quarter. Synthomer had a negative return on equity of 7.52% and a negative net margin of 4.40%. Equities analysts expect that Synthomer plc will post 12.962963 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Jonathan Silver bought 59,229 shares of the firm's stock in a transaction on Wednesday, August 6th. The stock was bought at an average price of GBX 65 ($0.87) per share, with a total value of £38,498.85 ($51,780.56). Also, insider Janet E. Ashdown bought 19,920 shares of the firm's stock in a transaction on Thursday, July 3rd. The shares were bought at an average cost of GBX 99 ($1.33) per share, with a total value of £19,720.80 ($26,524.28). In the last 90 days, insiders bought 99,149 shares of company stock valued at $7,101,965. Company insiders own 28.00% of the company's stock.

Synthomer Company Profile

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Featured Articles

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines